Viral Hepatitis
Viral hepatitis is a chronic liver disease that is often fatal. Hepatitis virus types A, B, C, D and E are known. Viriom concentrates on the most dangerous B and C types. WHO estimates that 325 million people globally are living with a hepatitis virus infection. Hepatitis virus is transmitted by blood, during sex, or from mother to child. Viral hepatitis is a global threat to public health.
Hepatitis b virus
• Global disease burden is 296 million people
• 1.5 million new infections each year
• 820,000 deaths in 2019 from liver failure or liver cancer
• Common co-infection of people living with HIV
Hepatitis C virus
• Global disease burden is 58 million people
• 1.5 million new infections each year
• 290,000 deaths in 2019, from liver failure or liver cancer
• Curative therapies exist but global access to diagnostics and treatments remains low
• No effective vaccine for Hepatitis C virus
Viriom's Global Antiviral Platform gives patients in low-income counties around the globe the hope for safer and more effective treatment alternatives that they would have not been able to afford otherwise. Learn more about our innovative pipeline and how Viriom delivers its promise of Hope, Health, and Happiness for all.